Naoual Bakrin is an expert in Surgery at Centre Hospitalier Lyon Sud (France). As of April 2026, ScienceLeadR ranks Naoual Bakrin in the top 1% of experts worldwide for Pressurized Intraperitoneal Aerosol Chemotherapy, Ovarian Neoplasms and Adnexal Diseases. Naoual Bakrin has authored 158 publications, the most recent in 2026, and is an investigator in 11 clinical trials, 2 of them ongoing. SLR score: 572 (community average: 125). How the SLR is computed.

LeadR Profile

Naoual Bakrin Centre Hospitalier Lyon Sud France
572 ScienceLeadR Reputation 572
Network Map

Surgery

Subspecialties: Oncology - Gynecology - Pharmacy

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2010 - 2026

Source: PubMed

Centre Hospitalier Lyon Sud

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 158

Citations

Citations: 3 667 1st author: 9 Last author: 17 Unique author: 0


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Principles of cytoreductive surgery for primary and metastatic peritoneal malignancies-the PSOGI-ESGO-ISSPP Lyon consensus.
PMID 41926971 — cytoreduction surgical procedures, neoplasms
Lancet Oncol Top journal20260
The PSOGI consensus on minimally-invasive surgery for peritoneal surface malignancy.
PMID 41777073 — minimally invasive surgical procedures, neoplasms, peritoneal neoplasms, general surgery
Br J Surg20260
Feasibility of ERAS guidelines for cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (CRS-HIPEC): An international multicenter study.
PMID 41666597 — cytoreduction surgical procedures, hyperthermia, induced, ovary, hyperthermic intraperitoneal chemotherapy, drug therapy, medical oncology, chemotherapy
Eur J Surg Oncol20260
Eco-responsible and rational interval debulking surgery for high-grade ovarian carcinomas: An observational, ambispective cohort study.
PMID 41650790 — carbon footprint, ovary, genital neoplasms, female, pathology, cohort studies, paraffin, ovarian neoplasms
Gynecol Oncol20260
Peritonectomy procedures for peritoneal surface malignancies: PSOGI-ESGO-ISSPP Lyon consensus.
PMID 40560098 — peritoneal neoplasms, general surgery, surgeons
Br J Surg20250

Clinical Studies 11

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1

By phase:

N/A 4
Phase 3 4
Phase 1/Phase 2 2
Phase 1 1

By status:

Active not recruiting 3
Recruiting 3
Completed 2
Unknown 2
Terminated 1

By type:

Interventional 9
Observational 2

By Monocentric/Multicentric:

monocentric 2
multicentric2to4 1
multicentric5to9 1
multicentricup10 7

Main Topics

Cohort/Consortium Investigators 1

Ongoing Clinical Trials

2 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
PROADAPT ovary EWOC 2
NCT04284969 — exercise, telephone, cytoreduction surgical procedures, respiration, pharmaceutical preparations, surgical procedures, operative, ovary, neoplasms, multiple chronic conditions, rehabilitation, aged, breathing exercises, ovarian neoplasms, therapeutics, surgeons, women
N/ARecruiting2021
Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Associated With Systemic Chemotherapy in Women With Advanced Ovarian Cancer
NCT04811703 — safety, cytoreduction surgical procedures, paclitaxel, aerosols, fallopian tube neoplasms, ovary, doxorubicin, neoplasms, drug therapy, ovarian neoplasms, peritoneal neoplasms, therapeutics, carboplatin, ca-125 antigen, carcinoma, ovarian epithelial, peritoneum, fallopian tubes, chemotherapy, carcinoma, pressurized intraperitoneal aerosol chemotherapy, women
Phase 1Recruiting2021

LeadR Networks

Main global connection map